Endoplast ApS: Financial statements 2024
CVR: 40866442
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Endoplast ApS (CVR 40866442) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 26,160 and a net result of DKK -19,064 compared with DKK 54,098 the year before. That is a decrease of 76.5% compared with the year before. Equity in the 2024 report amounted to DKK -368,540. The company had 1 employee in the financial year.
- Gross Profit
- DKK 26,160
- Profit/Loss
- DKK -19,064
- Equity
- DKK -368,540
- Total Assets
- DKK 360,596
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 26 t. | -19 t. | -369 t. | 1 |
| 2023 | - | 111 t. | 54 t. | -349 t. | 0 |
| 2022 | - | -463 t. | -376 t. | -404 t. | 0 |
| 2021 | - | -109 t. | -89 t. | -28 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Endoplast ApS has published its annual report for 2023. Gross profit came to DKK 111,350, and the net result was DKK 54,098.
About Endoplast ApS
Endoplast ApS is a Danish company of the type Anpartsselskab based in Hårlev, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Thomas Foldberg. The company is owned by TACC Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 168,968 and a net result of DKK 99,945 compared with DKK -19,064 the year before. Equity in the 2025 report amounted to DKK -268,595.